Similar artefact susceptibility for water- and air-filled urodynamic systems: a non-inferiority randomised controlled trial

IF 4.4 2区 医学 Q1 UROLOGY & NEPHROLOGY BJU International Pub Date : 2025-03-12 DOI:10.1111/bju.16706
Madlen M. E. Kasten, Oliver Gross, Marian S. Wettstein, Collene E. Anderson, Veronika Birkhäuser, Joëlle Borer, Miriam Koschorke, Martina D. Liechti, Shawna E. McCallin, Ulrich Mehnert, Raphael Röthlisberger, Helen Sadri, Lara Stächele, Thomas M. Kessler, Lorenz Leitner
{"title":"Similar artefact susceptibility for water- and air-filled urodynamic systems: a non-inferiority randomised controlled trial","authors":"Madlen M. E. Kasten,&nbsp;Oliver Gross,&nbsp;Marian S. Wettstein,&nbsp;Collene E. Anderson,&nbsp;Veronika Birkhäuser,&nbsp;Joëlle Borer,&nbsp;Miriam Koschorke,&nbsp;Martina D. Liechti,&nbsp;Shawna E. McCallin,&nbsp;Ulrich Mehnert,&nbsp;Raphael Röthlisberger,&nbsp;Helen Sadri,&nbsp;Lara Stächele,&nbsp;Thomas M. Kessler,&nbsp;Lorenz Leitner","doi":"10.1111/bju.16706","DOIUrl":null,"url":null,"abstract":"<div>\n \n <section>\n \n <h3> Objectives</h3>\n \n <p>To determine whether air-filled systems (AFS) provide comparable urodynamic investigation (UDI) trace quality to water-filled systems (WFS), the recommended standard by the International Continence Society.</p>\n </section>\n \n <section>\n \n <h3> Patients and Methods</h3>\n \n <p>A total of 490 patients undergoing UDI from April 2021 to January 2022 were included in this non-inferiority randomised controlled trial. Eligible patients were female and male adults with neurogenic lower urinary tract dysfunction (NLUTD). Patients were allocated by block randomisation in a 1:1 ratio to undergo UDI using a WFS (<i>n</i> = 244) or an AFS (<i>n</i> = 246). The primary endpoint was artefact susceptibility evaluated by a ‘blinded’ assessor using a modified ‘Bristol UTraQ’ quality scoring scale ranging from 0 to 18, with higher scores indicating a better quality. A clinically meaningful non-inferiority margin was pre-specified as −2 points on the quality scoring scale (AFS-WFS).</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>The median (interquartile range [IQR]) overall quality score was 14.5 (13.5–15.5) points for the WFS and 15.5 (14.5–16.5) points for the AFS. Inferiority of AFS could be rejected at the pre-specified non-inferiority margin (0.96, 95% confidence interval 0.68–1.25; <i>P</i> &lt; 0.001). Artefacts were more frequent in WFS. Typical artefacts consisted of repeat rectal contractions, poor pressure transmission during cough test at empty bladder, and detrusor resting pressure outside of the physiological range at empty bladder.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Our results indicate that AFS are non-inferior to WFS regarding overall urodynamic trace quality in patients with NLUTD.</p>\n </section>\n </div>","PeriodicalId":8985,"journal":{"name":"BJU International","volume":"135 6","pages":"1039-1048"},"PeriodicalIF":4.4000,"publicationDate":"2025-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BJU International","FirstCategoryId":"3","ListUrlMain":"https://bjui-journals.onlinelibrary.wiley.com/doi/10.1111/bju.16706","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives

To determine whether air-filled systems (AFS) provide comparable urodynamic investigation (UDI) trace quality to water-filled systems (WFS), the recommended standard by the International Continence Society.

Patients and Methods

A total of 490 patients undergoing UDI from April 2021 to January 2022 were included in this non-inferiority randomised controlled trial. Eligible patients were female and male adults with neurogenic lower urinary tract dysfunction (NLUTD). Patients were allocated by block randomisation in a 1:1 ratio to undergo UDI using a WFS (n = 244) or an AFS (n = 246). The primary endpoint was artefact susceptibility evaluated by a ‘blinded’ assessor using a modified ‘Bristol UTraQ’ quality scoring scale ranging from 0 to 18, with higher scores indicating a better quality. A clinically meaningful non-inferiority margin was pre-specified as −2 points on the quality scoring scale (AFS-WFS).

Results

The median (interquartile range [IQR]) overall quality score was 14.5 (13.5–15.5) points for the WFS and 15.5 (14.5–16.5) points for the AFS. Inferiority of AFS could be rejected at the pre-specified non-inferiority margin (0.96, 95% confidence interval 0.68–1.25; P < 0.001). Artefacts were more frequent in WFS. Typical artefacts consisted of repeat rectal contractions, poor pressure transmission during cough test at empty bladder, and detrusor resting pressure outside of the physiological range at empty bladder.

Conclusions

Our results indicate that AFS are non-inferior to WFS regarding overall urodynamic trace quality in patients with NLUTD.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
水和充气尿动力系统相似的人工产物敏感性:一项非劣效性随机对照试验
为了确定充气系统(AFS)是否提供与国际尿失禁协会推荐的标准——充水系统(WFS)相当的尿动力学调查(UDI)痕量质量。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
BJU International
BJU International 医学-泌尿学与肾脏学
CiteScore
9.10
自引率
4.40%
发文量
262
审稿时长
1 months
期刊介绍: BJUI is one of the most highly respected medical journals in the world, with a truly international range of published papers and appeal. Every issue gives invaluable practical information in the form of original articles, reviews, comments, surgical education articles, and translational science articles in the field of urology. BJUI employs topical sections, and is in full colour, making it easier to browse or search for something specific.
期刊最新文献
Beyond sensitivity: artificial intelligence and micro-ultrasonography in prostate cancer detection. Cytoreductive nephrectomy in the era of immune-checkpoint inhibitors: back to the future? Deep early tumour shrinkage in metastatic upper tract urothelial carcinoma treated with enfortumab vedotin plus pembrolizumab. Characteristics and outcomes of men presenting with complications of metastatic prostate cancer. Response to Lin et al.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1